We are live on ! Find out more
NA

NewEdge Advisors Portfolio holdings

AUM $27.7B
1-Year Est. Return 22.98%
This Fund
S&P 500
This Quarter Est. Return
+6.1%
1 Year Est. Return
+22.98%
3 Year Est. Return
+69.07%
5 Year Est. Return
+86.55%
10 Year Est. Return
+264.51%
AUM
$8.85B
AUM Growth
+$851M
Cap. Flow
+$412M
Cap. Flow %
4.65%
Top 10 Hldgs %
16.84%
Holding
3,702
New
289
Increased
1,323
Reduced
1,138
Closed
218

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$30.8M
2
UL icon
Unilever
UL
+$28.5M
3
CMCSA icon
Comcast
CMCSA
+$27.6M
4
ITW icon
Illinois Tool Works
ITW
+$27.1M
5
MDLZ icon
Mondelez International
MDLZ
+$26.8M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$30.6M
2
ABT icon
Abbott
ABT
+$28.3M
3
BMY icon
Bristol-Myers Squibb
BMY
+$27.8M
4
DOV icon
Dover
DOV
+$27.1M
5
ULST icon
State Street Ultra Short Term Bond ETF
ULST
+$24.4M

Sector Composition

Rank Sector Weight
1 Technology 12.26%
2 Financials 5.78%
3 Healthcare 5.7%
4 Consumer Discretionary 4.46%
5 Industrials 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BFLY.WS
3301
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$589 ﹤0.01%
2,500
– –
KZIA
3302
Kazia Therapeutics
KZIA
$146M
$580 ﹤0.01%
10
– –
CGEN icon
3303
Compugen
CGEN
$220M
$570 ﹤0.01%
500
-238
-32% -$207
SHYL icon
3304
Xtrackers Short Duration High Yield Bond ETF
SHYL
$267M
$565 ﹤0.01%
13
– –
RVMD icon
3305
Revolution Medicines
RVMD
$40.9B
$562 ﹤0.01%
21
– –
XSOE icon
3306
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund
XSOE
$2.01B
$559 ﹤0.01%
20
– –
DNA icon
3307
Ginkgo Bioworks
DNA
$528M
$558 ﹤0.01%
8
-587
-99% -$34.7K
TLPH icon
3308
Talphera
TLPH
$70.1M
$555 ﹤0.01%
500
-5
-1% -$4
PTRA
3309
DELISTED
Proterra Inc. Common Stock
PTRA
$535 ﹤0.01%
446
– –
GII icon
3310
State Street SPDR S&P Global Infrastructure ETF
GII
$932M
$534 ﹤0.01%
10
– –
DFTX
3311
Definium Therapeutics
DFTX
$5.91B
$528 ﹤0.01%
148
+133
+887% +$459
GOEV
3312
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$527 ﹤0.01%
2
– –
GDOT icon
3313
Green Dot
GDOT
$743M
$525 ﹤0.01%
28
– –
DAVA icon
3314
Endava
DAVA
$153M
$518 ﹤0.01%
10
– –
GTHX
3315
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$498 ﹤0.01%
200
– –
DAVE icon
3316
Dave Inc
DAVE
$4.8B
$496 ﹤0.01%
93
– –
GIL icon
3317
Gildan
GIL
$9.72B
$484 ﹤0.01%
15
– –
AINC
3318
DELISTED
Ashford Inc.
AINC
$477 ﹤0.01%
49
– –
RIOT icon
3319
Riot Platforms
RIOT
$8.36B
$473 ﹤0.01%
40
– –
XOMA
3320
DELISTED
Xoma
XOMA
$472 ﹤0.01%
25
-86
-77% -$1.61K
POR icon
3321
Portland General Electric
POR
$5.8B
$469 ﹤0.01%
10
+8
+400% +$396
PLM
3322
DELISTED
PolyMet Mining Corp.
PLM
$466 ﹤0.01%
590
-245
-29% -$368
PSFE icon
3323
Paysafe
PSFE
$434M
$464 ﹤0.01%
46
-7
-13% -$89
PALL icon
3324
abrdn Physical Palladium Shares ETF
PALL
$635M
$455 ﹤0.01%
20
-15
-43% -$400
GGZ
3325
Gabelli Global Small and Mid-Cap Value Trust
GGZ
$123M
$431 ﹤0.01%
36
– –
131 132
133
134 135

Similar funds

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
TWC
The Woodbridge Company Toronto, Ontario, Canada $27.8B AUM 46.78% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

NewEdge Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, NewEdge Advisors held 3,702 positions worth $8.85B, up 11% from $8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

NewEdge Advisors deployed $412M of net new capital in Q2 2023, opening 289 new positions and adding to 1,323 existing holdings. Its largest new stake was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Accenture, an estimated $30.6M trimmed.

  • NewEdge Advisors's largest Q2 2023 buy was Franklin International Core Dividend Tilt Index ETF: 317,686 shares worth $9.29M.
  • NewEdge Advisors added most to AbbVie in Q2 2023, an estimated $30.8M increase.
  • NewEdge Advisors's biggest Q2 2023 reduction was Accenture, cutting an estimated $30.6M.
  • NewEdge Advisors fully exited Quadratic Deflation ETF in Q2 2023, selling an estimated $3.13M.
  • NewEdge Advisors's ten largest holdings make up 17% of its $8.85B portfolio in Q2 2023.
  • NewEdge Advisors opened 289 new positions and closed 218 in Q2 2023.
  • NewEdge Advisors's portfolio value rose 11% quarter-over-quarter to $8.85B.

Based on NewEdge Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.